Commentary & Perspectives

Why AI, Cloud & Sustainability Strategies May Collide 

UK pharma’s digital ambition is starting to work against it, writes Martyn Williams of COPA-DATA UK

Share

  • 1

    UK pharma faces challenges in digital transformation by

  • 2

    Conflicting digital initiatives can create operational friction.

  • 3

    Over-customization impedes successful project scalability.

  • 4

    Hidden costs of AI usage may clash with sustainability goals.

  • 5

    Rethinking data management is crucial for efficiency.

  • 6

    The investment context for life sciences remains cautious.

  • 7

    Manufacturers should standardize rather than over-customize.

Original Source(s)

Why AI, Cloud & Sustainability Strategies May Collide 

UK pharma’s digital ambition is starting to work against it, writes Martyn Williams of COPA-DATA UK

  • by Martyn Williams

  • February 16, 2026

  • 5 min

Related Content

When Inflammation Fuels Cancer in the IBD Colon

Researchers identify immune pathways that link long-term inflammation to tumor development

  • February 9, 2026

  • 3 min
The Unexpected Risks of Liquid Nitrogen Ingestion 

A case report describes gastric perforation following ingestion of a liquid nitrogen–infused drink 

Biomarkers Expand Precision in CRC

Emerging biomarkers guide colorectal cancer diagnosis, stratification, and treatment selection